Isobenzofuran analog of sclerophytin A (5d) small molecule

Naturally occurring products 2, 11 cyclized cembranoids have been shown to inhibit the growth of KB3 nasopharyngeal carcinoma. The standard cancer cell line used to test for chemotherapy effectiveness. The bicyclic hydroisobenzofuran is the beneficial compounds that are naturally occurring in 2, 11 cyclized cembranoids. This compound has shown inhibition of growth of KB3 cancer […]

Contributors

Inventor Institute
Matt McIntosh University of Arkansas, Fayetteville
Cat. #: 158006
Research Fields: Cancer
Product description: Naturally occurring products 2, 11 cyclized cembranoids have been shown to inhibit the growth of KB3 nasopharyngeal carcinoma. The standard cancer cell line used to test for chemotherapy effectiveness. The bicyclic hydroisobenzofuran is the beneficial compounds that are naturally occurring in 2, 11 cyclized cembranoids. This compound has shown inhibition of growth of KB3 cancer test cells and could be used in cancer and antibiotics research.
Shipping conditions: Dry Ice
References:

Bateman et al. 2009. Bioorg Med Chem Lett. 19(24):6898-901. PMID: 19896844.

Related Tools for Small molecules

Cat. # Tool Name
151833 Chk2 inhibitor CCT241533 Small Molecule (Tool Compound) Key Info View Tool
151839 Antitumoral Phortress Small Molecule (Tool Compound) Key Info View Tool
152741 Platinum trimethyl Luminophore Small Molecule (Tool Compound) Key Info View Tool
153255 Autotaxin Inhibitor (CRT0273750) Small Molecule (Collaborative Toolkit) Key Info View Tool
153334 HDAC3:SMRT Fluorescent Probe 2-FAM-InsP5 Small Molecule (Tool Compound) Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.